Uncategorized
Implantable Miniature Telescope retains positive results in 5-year follow-up
The Implantable Miniature Telescope showed favorable safety and efficacy outcomes for treating end-stage age-related macular degeneration over the long term, particularly in patients younger than 75 years old, according to a study.The prospective, open-label, multicenter clinical trial, a continuation of the 24-month IMT-002 study, evaluated 63 patients with the IMT (VisionCare Ophthalmic Technologies) 60 months after surgery, with 31 patients ranging from 65 to 74 years old in group 1 and 32 patients age 75 years or older in group 2.